Keeping your kidneys healthy is one of the most important things you can do for your overall well-being, yet many Americans ...

Baseline kidney function could help identify who is at greater risk for developing chronic kidney disease following cisplatin ...

A randomized trial tested the potential additive benefit of active vitamin D in reducing proteinuria in patients with IgA nephropathy.

Imlifidase, an IgG-destroying enzyme, could receive FDA approval in the second half of 2026 and hit peak sales of $306 ...

Hailed as ‘super food', chia seeds are extremely popular around the world. These tiny seeds are undoubtedly rich in fiber, ...

Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced positive topline results from the US Phase 3 ConfIdeS trial of imlifidase, evaluating 12-month kidney function ...

Treating constipation with lubiprostone may confer renal benefits in chronic kidney disease by modulating microbiome-driven ...

Data show results consistent with clinical trial experienceA high level of safety – no device-related adverse eventsStrong survival data ...

With more than 25 years of clinical leadership, we’ve developed a connected ecosystem that brings together diabetes ...

Explore practical implications of new research in nephrotic syndrome, from renal biopsy and genetic testing to managing ...

IgA nephropathy may shorten life expectancy. The kidney disease may reduce how long you live by about 10 years.

Back in 2002, Rentia le Roux received a horrifying diagnosis that her kidneys were failing. “My kids still need me, they are still small, what are we going to do?” Le Roux recalls telling her doctor.